Ownership history in Values First Advisors, Inc. · 13 quarters on record
This page tracks every 13F SEC filing in which Values First Advisors, Inc. reported a position in ACELRX PHARMACEUTICALS INC (TLPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 81,208 | -16,674 | -17.0% | 0.05% | $93K | $1.14 |
| 2025 Q3 | REDUCED | 97,882 | -1,329 | -1.3% | 0.05% | $87K | $0.89 |
| 2025 Q2 | ADDED | 99,211 | +1,887 | +1.9% | 0.02% | $46K | $0.46 |
| 2025 Q1 | ADDED | 97,324 | +771 | +0.8% | 0.03% | $49K | $0.50 |
| 2024 Q4 | REDUCED | 96,553 | -14,777 | -13.3% | 0.03% | $51K | $0.52 |
| 2024 Q3 | REDUCED | 111,330 | -1,845 | -1.6% | 0.05% | $95K | $0.86 |
| 2024 Q2 | REDUCED | 113,175 | -240 | -0.2% | 0.06% | $101K | $0.89 |
| 2024 Q1 | REDUCED | 113,415 | -21,823 | -16.1% | 0.07% | $117K | $1.03 |
| 2023 Q4 | ADDED | 135,238 | +12,773 | +10.4% | 0.06% | $99K | $0.74 |
| 2023 Q3 | ADDED | 122,465 | +24 | +0.0% | 0.05% | $71K | $0.58 |
As of 2025 Q4 — sorted by position size